Result Q3
PRIVI SPECIALITY CHEM Q3FY24 CONS
NET PROFIT 29 CR VS 6 CR (YOY) , Q2 30 CR
REVENUE 404 CR VS 420 CR (YOY), Q2 455 CR
EBITDA 90 CR VS 47 CR (YOY) , Q2 86 CR
EBITDA MARGIN 22% VS 12% (YOY) , Q2 20%
Margin Expansion
PRIVI SPECIALITY CHEM Q3FY24 CONS
NET PROFIT 29 CR VS 6 CR (YOY) , Q2 30 CR
REVENUE 404 CR VS 420 CR (YOY), Q2 455 CR
EBITDA 90 CR VS 47 CR (YOY) , Q2 86 CR
EBITDA MARGIN 22% VS 12% (YOY) , Q2 20%
Margin Expansion
JV with Givaudan commence operations in Oct 2024, capital expenditure of 178 cr.
The JV initially targets to manufacture a broad portfolio of value added products with a progressive ramp up in activities over the next two to three years.
The joint venture’s infrastructure has also been expanded with an additional 5-acre area, adjacent to the existing 4-acre site, laying the foundation for significant future growth.
Prigiv Joint Venture – A Transformational Move
Privi has partnered with Givaudan, a global leader in fragrances and flavors, to establish Prigiv, a 51:49 joint venture
The commercialization of PRIGIV, a joint venture with Givaudan.
Under this exclusive agreement, Privi will be the sole supplier of these specialty chemicals to Givaudan, ensuring steady long-term revenue and reducing demand fluctuations. This partnership aligns with Privi’s strategy of securing stable, long-term contracts with major global players, further insulating the business from cyclical downturns.
Additionally, Privi’s backward integration capabilities will allow it to supply raw materials to Prigiv at competitive costs, optimizing production efficiency and profitability. The initial projected revenue from Prigiv is ₹150 crore annually, with the potential to double in the coming years as production scales up. Even before full-scale operations, Givaudan has requested an expansion of the facility, leading Privi to acquire additional land near the Prigiv plant for future growth.
Privi Specialty Chemicals is seeing strong growth in exports and realizations, fueled by a rising mix of higher-value products. Momentum is clearly building!
Outstanding result for Q4FY25
Good numbers, beat on revenue as well as on the margins. But numbers may have been pumped up ahead of QIP.
Where is the news of qip?
Last year QIP was approved by the board, BSE filing in July 2024 contains information about it. Recently I heard somewhere that QIP is going to happen soon.
They can fool retail investors but how come fund houses get trapped?. They might have seen like this many so they have metrics checks and balances. Let’s see how it goes
Fund houses are the ones who participated hugely in QIPs and even the overpriced IPOs. Look at the QIPs in last 2 years, major mutual funds and institutional investors participated in them and most of the QIP stocks like cello, Sheela foam, Zomato, IDFC first and so on, they are trading well below QIP price…retailers are not the only ones who get trapped or fooled